Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines

SIMPLE SUMMARY: Dendritic cells (DCs)-based anti-cancer vaccines displayed limited efficacy in clinical trials, mostly due to a lack of protocols for preparing immunogenic tumor antigens used in the vaccine. Here, a unique atmospheric pressure plasma jet was used to prepare a plasma-activated medium...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomić, Sergej, Petrović, Anđelija, Puač, Nevena, Škoro, Nikola, Bekić, Marina, Petrović, Zoran Lj., Čolić, Miodrag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037863/
https://www.ncbi.nlm.nih.gov/pubmed/33915703
http://dx.doi.org/10.3390/cancers13071626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037863/
https://www.ncbi.nlm.nih.gov/pubmed/33915703
http://dx.doi.org/10.3390/cancers13071626

Ejemplares similares